CoChat

eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer

Open access
Müller, David, Shin, Sauyeun, Goullet de Rugy, Théo, Samain, Rémi, Baer, Romain, Strehaiano, Manon, Masvidal-Sanz, Laia, Guillermet-Guibert, Julie, Jean, Christine, Tsukumo, Yoshinori, Sonenberg, Nahum, Marion, Frédéric, Guilbaud, Nicolas, Hoffmann, Jean-Sébastien, Larsson, Ola, Bousquet, Corinne, Pyronnet, Stéphane, Martineau, Yvan · 2019 · JCI Insight
Cited by 43

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) relies on hyperactivated protein synthesis. Consistently, human and mouse PDAC lose expression of the translational repressor and mTOR target 4E-BP1. Using genome-wide polysome profiling, we here explore mRNAs whose translational efficiencies depend on the mTOR/4E-BP1 axis in pancreatic cancer cells. We identified a functional enrichment for mRNAs encoding DNA replication and repair proteins, including RRM2 and CDC6. Consequently, 4E-BP1 depletion favors DNA repair and renders DNA replication insensitive to mTOR inhibitors, in correlation with a sustained protein expression of CDC6 and RRM2, which is inversely correlated with 4E-BP1 expression in PDAC patient samples. DNA damage and pancreatic lesions induced by an experimental pancreatitis model uncover that 4E-BP1/2-deleted mice display an increased acinar cell proliferation and a better recovery than WT animals. Targeting translation, independently of 4E-BP1 status, using eIF4A RNA helicase inhibitors (silvestrol derivatives) selectively modulates translation and limits CDC6 expression and DNA replication, leading to reduced PDAC tumor growth. In summary, 4E-BP1 expression loss during PDAC development induces selective changes in translation of mRNA encoding DNA replication and repair protein. Importantly, targeting protein synthesis by eIF4A inhibitors circumvents PDAC resistance to mTOR inhibition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.121951

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 43

Metadata

Authors
Müller, D., Shin, S., Goullet de Rugy, T., Samain, R., Baer, R., Strehaiano, M., Masvidal-Sanz, L., Guillermet-Guibert, J., Jean, C., Tsukumo, Y., Sonenberg, N., Marion, F., Guilbaud, N., Hoffmann, J.-S., Larsson, O., Bousquet, C., Pyronnet, S., & Martineau, Y.
Venue
JCI Insight
Published
2019-11-01
Volume
4
Issue
21
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2984380359
Cited by
43
References
12
FWCI
2.01
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. https://app.cochat.ai/papers/10.1172/jci.insight.121951
The paper
Müller, D., Shin, S., Goullet de Rugy, T., Samain, R., Baer, R., Strehaiano, M., Masvidal-Sanz, L., Guillermet-Guibert, J., Jean, C., Tsukumo, Y., Sonenberg, N., Marion, F., Guilbaud, N., Hoffmann, J.-S., Larsson, O., Bousquet, C., Pyronnet, S., & Martineau, Y. (2019). eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. JCI Insight. https://doi.org/10.1172/jci.insight.121951

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.